Everyday Health on MSN
How to plan for successful home SCIg self-administration for primary immunodeficiency
Learn how to self-administer SCIg at home for primary immunodeficiency. Tips on preparation, reducing pain, managing ...
As Lindsey Vonn’s comeback run heads toward a peak with Team USA at the upcoming 2026 Winter Olympics, Invivyd is adding the ...
Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...
Explore the complexities of modern oncology, including precision medicine, CAR T-cell therapies, and challenges in breast ...
NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) and the SPEAR Study Group today announced the plan to initiate a Phase 2 clinical trial evaluating monoclonal antibody ...
Before Jackson took office at ARPA-H, the agency’s chief data officer departed after disagreeing with the administration’s ...
Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, ...
Cone Health rethinking infusion aligns services, standardizes workflows and boosts capacity across oncology and non-oncology sites.
Dr. Ian Flinn explains in an interview with CURE how Lunsumio VELO (mosunetuzumab) works and its impact on patients with ...
SurvivorNet on MSN
Cancer patients are living longer — a closer look at the treatments driving this progress
New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...
Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...
AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results